Although new social media such as Twitter provide a "rich environment," loaded with information, that information is "full of noise" making it "diffıcult to extract signals," says John Brownstein of Harvard Medical School in Boston, Mass. Once extracted, however, those signals provide a novel means for tracking infectious disease outbreaks in advance of formal notices while usually skirting any efforts to suppress that information, he says. Brownstein and Neil Ferguson of Imperial College London in London, United Kingdom, spoke during a plenary session, "The Use of Social Media and New Technologies in Healthcare," convened during the 2012 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), held in San Francisco, Calif., last September.
Those who are trying to build more conventional means with which to evaluate, follow the dynamics, and perhaps predict the outcomes of epidemics may start their efforts with better datasets, but they still confront vast amounts of information in building such models, according to Ferguson. Part of the "art of modeling," he says, is knowing "what to leave out." However, another part is deciding what needs to be included, he continues. "Historically, infectious disease modelers omitted geography, but such models need to be spatial." Growth in computing power enables modelers to include such parameters, capturing data on human travel within that more static geography. .
O'Toole and his collaborators relied on deep DNA sequencing to profıle the bacterial communities in sputum samples collected from adult CF patients. The cohort included 22 patients whose disease was considered stable and another 13 patients undergoing acute exacerbations. It is one of the largest studies so far to use deep sequencing technology for so many samples.
Disease stability among CF patients correlates not only with the diversity of microbial species but also with a high prevalence in their lungs of Streptococcus species, including both commensal oral species and the S. milleri pathogenic species. This fınding was "a surprise," O'Toole says, noting that other researchers report S. milleri species being associated with CF patients experiencing exacerbations. Perhaps even more surprising, O'Toole and his collaborators report that the presence of Pseudomonas aeruginosa negatively correlates with the clinical status of such patients, despite other reports to the contrary. Additionally, P. aeruginosa was predominant in only about half the CF patients who were part of this cohort, according to O'Toole.
These fındings point to the complexity of microbial communities in the lungs of patients with chronic CF, O'Toole continues. That complexity sharply contrasts with the conventional and rather simple approach being followed in managing such patients, in which "an antibiotic treatment regimen is typically dictated by the fındings of plate-based culture results looking at a handful of pathogens historically identifıed in cystic fıbro-sis," he says. "To improve patient treatment, we must fully understand the polymicrobial lung communities, their dynamics, and interactions."
Taking that idea a step further, he says "We propose that increased bacterial diversity is important for [CF] patient stability and that Streptococcus may play an important role in promoting such diversity."
Knowledge from this and similar studies may make it possible to mold the bacterial community into one that is more favorable to patients with CF, according to John LiPuma of the University of Michigan in Ann Arbor, who was not involved in the research. "These analyses are diffıcult due to the confounding of disease progression, antibiotic use, and decreased diversity," he says. "Although associations are found, the linear causality is unclear. Studies that carefully quantify and control for antibiotic use are needed to sort this out." The research also is important because the fıeld has hit a plateau with its dependence on antibiotics, and needs new management strategies to further extend the life expectancy of CF patients, he points out.
David C. Holzman is the Microbe Journal Highlights Editor

PUBLIC HEALTH
Deadly Resurgence of West Nile Virus Puzzles U.S. Health Officials Marlene Cimons
The United States is experiencing an unusually high number of human infections from West Nile virus (WNV). The number of reported cases is the highest through the third week of October since 2003, according to offıcials at the Centers for Disease Control and Prevention (CDC) in Atlanta, Ga.
MINITOPIC
Reduced Estimates for Seafloor Microbes Drops Totals for Globe
Because sedimentary microbes below the seafloor vary by several orders of magnitude from site to site, estimates for their overall abundance need adjusting downward, according to Jens Kallmeyer of the Institut fúr Erd-und Umweltwissenschaften at the Universität Potsdam in Potsdam, Germany, and his collaborators there and in the United States. They estimate microbial totals in ocean sediments to be 2.9 ϫ 10 29 cells, noting that it is "much lower than previous estimates." One important upshot is that they estimate the global total for microbial cells to be 50 -78% lower than previously thought, while the biomass estimate is lowered by 10 -45%, they say. Details appear in the August 29, 2012 Proceedings of the National Academy of Sciences (www.pnas.org/cgi/doi/10.1073/ pnas.1203849109).
Moreover, the toll likely will rise, possibly exceeding 2002 and 2003, when about 3,000 cases of neuroinvasive disease and more than 260 deaths occurred each year, according to CDC. Of 4,531 cases through mid-October, 2,293 were neuroinvasive and 2,238 were non-neuroinvasive. Thus far, 183 people have died this year from those infections. While 48 states reported WNV in people, birds, or mosquitoes (Alaska and Hawaii report no activity), almost 70% of the human infections were confıned to eight states-Texas, California, Mississippi, Louisiana, Oklahoma, South Dakota, Michigan, and Illinois-with one-third of them (1,438 cases, 54 deaths) in Texas.
CDC offıcials say that numerous factors are involved in the current outbreak, but point to excessive heat affecting much of the country as likely a major reason for increases in WNV infections in mosquitoes and birds. Additionally, March was the warmest on record for the 48 contiguous United States, with more than 15,000 warm temperature records broken, according to the offıcials from the National Oceanic and Atmospheric Administration.
"Arboviral amplifıcation depends on several critical factors differentially influenced by weather," says Lyle R. Petersen, director of the CDC division of vector-borne diseases. "In particular, mosquitoes become more infectious faster when ambient temperature is increased. Heat could have also condensed pools of water, producing the small, nutrient-rich pools of water that Culex mosquitoes like to breed in. Thus, WNV outbreaks variably have been related to heat waves-including the outbreaks in 2002 and 2003, which didn't have a heat wave as severe as this year, but temperatures were above normal. However, most areas experiencing heat waves do not have outbreaks, suggesting the influence of many other factors. Too much rainfall washes out breeding sites."
While Texas is suffering a drought that began in October 2010 and continued through 2012, "many areas hard hit by the WNV outbreak had near normal rainfall," Petersen continues. "In addition, artifıcial irrigation throws a monkey wrench into any analysis such as this. Cities have lots of water, even in droughts. Thus, we see outbreaks in places like Phoenix. Bottom line-it's complicated!"
Other important factors include the number of birds, both susceptible and immune to the virus. Furthermore, although scientists are trying to determine whether WNV mutated, there is no evidence "to suggest that this outbreak was caused by a change in the virus itself," Petersen says.
Marlene Cimons lives and writes in Bethesda, Md.
MINITOPIC
Not "Strads," but Fungus-Treated Violins Sound Good
Treating wood from spruce and sycamore trees with two species of fungi, Physisporinus vitreus and Xylaria longipes, improves the tonal quality of modern stringed instruments that are made with that wood, making them sound more like the renowned violins that were made by Antonio Stradiavari and his coworkers during the 17th and 18th centuries in Italy, according to Francis W. M. R. Schwarze of the Swiss Federal Laboratories for Materials Science and Technology in St. Gallen, Switzerland. He says that these fungi gradually thin the cell walls of such trees, but leave intact a scaffold structure through which "sound waves can still travel directly." Whether that activity yields wood that rivals material found in much-revered "Strads," however, remains an unsettled debate. Schwarze spoke last September during a symposium convened at the Max Delbrúck Center for Molecular Medicine and Charité-Universitätsmedizin in Berlin-Buch, Germany. The conductive pili, or nanowires, of the bacterium Geobacter sulfurreducens carry a catalytically active uranium reductase that converts soluble uranium (IV), which is toxic, into a mineral form that is insoluble and thus no longer toxic, according to Gemma Reguera and her colleagues at Michigan State University in East Lansing. These bacteria may prove useful for treating sites contaminated with this toxic metal. Details appear in the September 6, 2011, Proceedings of the National Academy of Sciences (doi: 10.1073/pnas.1108616108).
The numbers and lengths of pili on the surfaces of G. sulfurreducens cells correlate with their capacity to convert uranium (IV) into an insoluble form, according to Reguera. Such pili can extend several micrometers from the cell surface, providing extensive redoxactive surface area to bind and reduce uranium (VI). Based on analysis using X-ray absorption spectroscopy, extracellular uranium reduction per cell increases when pili genes are being expressed at high levels. Moreover, soluble hexavalent uranium is immobilized along the pili as mononuclear tetravalent uranium forms complexes with carbon-containing ligands there.
Pili levels also correlate with respiratory activity and cell viability, according to Reguera. "We also found that the pili prevented the uranium from permeating inside the cell envelope and killing the cell," she says.
Soluble uranium that contaminates ground and surface waters is a vexing pollutant that has some researchers seeking to identify microorganisms to bioremediate sites where it is present. A key challenge was to fınd microbes that can convert dissolved uranium into a water-insoluble form that will not leach from such sites and threaten others. In situ bioremediation of uranium holds signifıcant promise for stabilizing U(VI) in groundwater at reduced costs compared to conventional processes.
"Microorganisms such as Geobacter sulfurreducens . . . are of high importance to the fıeld of bioremediation," says Lala Behari Sukla, Emeritus Scientist at the CSIR-Institute of Minerals and Materials Technology in Bhubaneswar, Orissa, India. However, "This promise can only be realized when researchers and practitioners successfully predict, demonstrate, and test the long-term effectiveness of uranium bioremediation protocols. Additional disposal issues and cost are concomitant with excavation of contaminated soil or pumping and treating water. The catalytic and protective cellular mechanism of Geobacter conductive pili involved in extracellular reduction of uranium highlighted in these fındings further scale up studies that can open new doorways for in situ bioremediation strategies."
Barry E. DiGregorio is a freelance writer in Middleport, N.Y.
RESEARCH ADVANCES
Microbial Polyesters Find Multiple Uses as External Biobeads Carol Potera
Some bacteria make and maintain biodegradable beads-biobeads, made of polyesters and capable of incorporating proteins-along their outer surfaces, according to Bernd Rehm, professor and chair of microbiology at Massey University in Palmerston North, New Zealand. "Beads with desired protein functions are manufactured in one step inside the bacterial cell and, using our molecular tool box, displayed at the bead surface," he says. Years of biobeads research are summarized in his review, which appears in the May/June, 2012 Bioengineered Bugs (doi:10.4161/bbug.19567).
In proof-of-principle experiments, Rehm and others attached different kinds of protein to biobeads, including green fluorescent protein, antigens, enzymes, signal proteins, and antibodies-in some cases, including three separate protein-based functions in a single set of biobeads. Much of this research relied on Escherichia coli, a workhorse bacterium prized for its tractability. It and other bacteria, when nutritionally stressed, form such polymer inclusions to store carbon and energy, depending on polyester synthases to generate each bead. Other types of bacteria, including species of Bacillus and Lactococcus, also generate such beads.
A leading application for biobeads is as vaccine components, according to Rehm. For instance, biobeads carrying the Ag85A-ESAT-6 Mycobacterium tuberculosis antigen induce a potent immune response in mice, protecting them about as well as the BCG vaccine against challenge, he says. If engineered instead with an antigen from the hepatitis C virus (HCc) and then used to inoculate mice, such biobeads produce specifıc and elevated immune responses in the animals. Although the polymer core of biobeads produces no adverse reactions on its own, vaccines made from E. coli-based biobeads can become contaminated with endotoxins and cause side effects. Such vaccines made using L. lactis cells appear safer. Efforts to develop a biobead vaccine to protect against tuberculosis are under way in the United States and New Zealand.
Additionally, biobeads can be used for protein purifıcations, immunoprecipitations, bioremediation, detoxifı-cation, imaging, and in diagnostic kits. In pharmaceutical manufacturing, biobeads coated with specifıc enzymes and incorporated into columns over which chemical ingredients are run serve as catalysts to modify drug in-termediates or other pharmaceutical products.
"The concept of using functionalized polyester beads produced by bacterial factories as carriers for proteins enables many industrial and medical applications," says Robert Hancock, a professor of microbiology and immunology at the University of British Columbia, Vancouver, Canada. "The method provides a credible alternative that could enjoy considerable success."
On an industrial scale, microbially engineered biobeads can replace products based on chemical resins, which are expensive and polluting. For example, protein A resin beads, a standard lab tool, require toxic solvents to make and still need to be attached separately to synthesized proteins, according to Rehm. Members of his team isolated the binding region of Protein A, called the "Z" domain, and cloned it into a vector to produce biobeads called PolyBindZ. They plan to sell PolyBindZ at a fraction of the cost of protein A resin beads through PolyBatics, a company, also based in Palmerston North, that Rehm helped to found. points out Angela Douglas of Cornell University in Ithaca, N.Y., citing research by Stanley Hazen of the Cleveland Clinic in Cleveland, Ohio, and his collaborators. They fınd that gut microflora digest dietary lipids into products that can induce atherosclerosis and heart disease in mice and, possibly, in humans.
Specifıcally, gut bacteria convert the dietary lipid phosphatidylcholine (PC) into trimethylamine (TMA), which the liver converts into trimethylamine-Noxide (TMAO). TMAO induces atherosclerotic plaques via cholesterolladen macrophage foam cells in mice. In humans, cardiovascular disease phenotypes such as peripheral and coronary artery disease, myocardial infarction, and atherosclerotic plaque burden also strongly correlate with elevated levels of TMAO.
Although high-fat diets increase the risk of cardiovascular disease, these fındings suggest that the lipids themselves may not be to blame. Strikingly, mice treated with antibiotics to suppress gut microbiota show no ill effects when fed the same high-fat diet. "Manipulation of commensal microbial composition by appropriately designed probiotic/antibiotic intervention may offer a novel therapeutic approach for the prevention and treatment of atherosclerotic heart disease and its complications . . . by bypassing this pathogenic microbe-mediated metabolic pathway," Hazen notes.
Shannon Weiman is a freelance writer in San Francisco, Calif.
MINITOPIC
Soil Microbes Affect Exchanges of Carbon, Drug Resistance Genes
When atmospheric carbon dioxide levels rise, arbuscular mycorrhizal fungi (AMF) that associate with plant roots apparently activate soil bacteria to metabolize organic matter and thereby release more carbon into the atmosphere-raising doubts about the capacity of soil to sequester carbon dioxide, according to Thomas Rufty of North Carolina State University in Raleigh and his collaborators there and other institutions in the United States and China. Details appear in the August 31, 2012 Science (337:1084). Separately, soil bacteria contain cassettes encoding genes conferring resistance to as many as five classes of antibiotics that apparently are being actively transferred to and from human pathogens, according to Gautam Dantas of Washington University School of Medicine in St. Louis, Mo., and collaborators. "I suspect the soil is not a teeming reservoir of resistance genes," he says. "But if factory farms or medical clinics continue to release antibiotics into the environment, it may enrich that reservoir, potentially making resistance genes more accessible to infectious bacteria." Details appear in the same issue of Science (337:1107). 
